HC Wainwright Expects Lower Earnings for CytomX Therapeutics
CytomX Therapeutics, Inc. (NASDAQ:CTMX – Free Report) – Analysts at HC Wainwright cut their Q2 2025 earnings per share estimates for shares of CytomX Therapeutics in a note issued to investors on Thursday, May 15th. HC Wainwright analyst M. Kapoor now forecasts that the biotechnology company will post earnings of $0.02 per share for the […]
CytomX Therapeutics, Inc. (NASDAQ:CTMX – Free Report) – Analysts at HC Wainwright cut their Q2 2025 earnings per share estimates for shares of CytomX Therapeutics in a note issued to investors on Thursday, May 15th. HC Wainwright analyst M. Kapoor now forecasts that the biotechnology company will post earnings of $0.02 per share for the […]
